105 related articles for article (PubMed ID: 15132575)
1. A convenient synthesis of a selective gelatinase inhibitor as an antimetastatic agent.
Lim IT; Brown S; Mobashery S
J Org Chem; 2004 May; 69(10):3572-3. PubMed ID: 15132575
[TBL] [Abstract][Full Text] [Related]
2. N-substituted homopiperazine barbiturates as gelatinase inhibitors.
Wang J; Medina C; Radomski MW; Gilmer JF
Bioorg Med Chem; 2011 Aug; 19(16):4985-99. PubMed ID: 21764590
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.
Lee M; Bernardo MM; Meroueh SO; Brown S; Fridman R; Mobashery S
Org Lett; 2005 Sep; 7(20):4463-5. PubMed ID: 16178559
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of a highly selective gelatinase inhibitor generates active metabolite.
Lee M; Villegas-Estrada A; Celenza G; Boggess B; Toth M; Kreitinger G; Forbes C; Fridman R; Mobashery S; Chang M
Chem Biol Drug Des; 2007 Nov; 70(5):371-82. PubMed ID: 17927722
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A.
Ikejiri M; Bernardo MM; Meroueh SO; Brown S; Chang M; Fridman R; Mobashery S
J Org Chem; 2005 Jul; 70(14):5709-12. PubMed ID: 15989356
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.
Gooyit M; Lee M; Hesek D; Boggess B; Oliver AG; Fridman R; Mobashery S; Chang M
Chem Biol Drug Des; 2009 Dec; 74(6):535-46. PubMed ID: 19824893
[TBL] [Abstract][Full Text] [Related]
7. Efficient synthesis of benzamide riboside, a potential anticancer agent.
Bonnac LF; Gao GY; Chen L; Patterson SE; Jayaram HN; Pankiewicz KW
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1249-53. PubMed ID: 18066762
[TBL] [Abstract][Full Text] [Related]
8. Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor.
Suzuki T; Hisakawa S; Itoh Y; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
Bioorg Med Chem Lett; 2007 Mar; 17(6):1558-61. PubMed ID: 17257837
[TBL] [Abstract][Full Text] [Related]
9. 1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities.
Lin R; Connolly PJ; Huang S; Wetter SK; Lu Y; Murray WV; Emanuel SL; Gruninger RH; Fuentes-Pesquera AR; Rugg CA; Middleton SA; Jolliffe LK
J Med Chem; 2005 Jun; 48(13):4208-11. PubMed ID: 15974571
[TBL] [Abstract][Full Text] [Related]
10. Total synthesis of spiruchostatin B, a potent histone deacetylase inhibitor, from a microorganism.
Takizawa T; Watanabe K; Narita K; Oguchi T; Abe H; Katoh T
Chem Commun (Camb); 2008 Apr; (14):1677-9. PubMed ID: 18368162
[TBL] [Abstract][Full Text] [Related]
11. A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition.
Lee M; Celenza G; Boggess B; Blase J; Shi Q; Toth M; Bernardo MM; Wolter WR; Suckow MA; Hesek D; Noll BC; Fridman R; Mobashery S; Chang M
Chem Biol Drug Des; 2009 Feb; 73(2):189-202. PubMed ID: 19207421
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors.
Li YL; Xu WF
Bioorg Med Chem; 2004 Oct; 12(19):5171-80. PubMed ID: 15351400
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of (4-phenoxyphenylsulfonyl) methylthiirane, a selective gelatinase inhibitor.
Celenza G; Villegas-Estrada A; Lee M; Boggess B; Forbes C; Wolter WR; Suckow MA; Mobashery S; Chang M
Chem Biol Drug Des; 2008 Mar; 71(3):187-96. PubMed ID: 18221479
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of novel galloyl pyrrolidine derivatives as potential anti-tumor agents.
Li X; Li Y; Xu W
Bioorg Med Chem; 2006 Mar; 14(5):1287-93. PubMed ID: 16213145
[TBL] [Abstract][Full Text] [Related]
15. Drug evaluation: MGCD-0103, a histone deacetylase inhibitor for the treatment of cancer.
Kell J
Curr Opin Investig Drugs; 2007 Jun; 8(6):485-92. PubMed ID: 17621879
[TBL] [Abstract][Full Text] [Related]
16. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
[TBL] [Abstract][Full Text] [Related]
17. Novel autoxidative cleavage reaction of 9-fluoredenes discovered during synthesis of a potential DNA-threading indenoisoquinoline.
Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Org Chem; 2004 Oct; 69(22):7495-501. PubMed ID: 15497974
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
19. 5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase.
Ballard P; Bradbury RH; Hennequin LF; Hickinson DM; Johnson PD; Kettle JG; Klinowska T; Morgentin R; Ogilvie DJ; Olivier A
Bioorg Med Chem Lett; 2005 Oct; 15(19):4226-9. PubMed ID: 16055332
[TBL] [Abstract][Full Text] [Related]
20. Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation.
Li Q; Li T; Zhu GD; Gong J; Claibone A; Dalton C; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Bauch JL; Marsh KC; Bouska JJ; Arries S; De Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1679-85. PubMed ID: 16403626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
